Catalyst Wire Dossier Catalyst Wire Dossier

GX-30

· Genexine, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GX-30, covering 2020-09-09 to 2020-09-09. Get the full timeline:

Most recent: Clinical Trial Update: Tolerability, Safety and Pharmacokinetics Study of GX-30 in Total Thyroidectomy or Near Total Thyroidectomy Patients [Phase 1, Phase 2]

See pricing